Picture of Canbridge Pharmaceuticals logo

1228 Canbridge Pharmaceuticals Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Canbridge Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line-218-846-1,077-483
Depreciation
Amortisation
Non-Cash Items97.862944929.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-9.8647.425151
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities-126-152-587-281
Capital Expenditures-42.5-153-5.33-34.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.05601310
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-42.4-153126-34.8
Financing Cash Flow Items-1.73-6.24-33.1-16.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities97679854-20.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-71.4347385-295